Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats

American Journal of Veterinary Research

Volumn 58, Issue 8, 1997, Pages 872-877

  Boothe, D M ^a   Herring, I ^b   Calvin, James ^a   Way, Nelson ^a   Dvorak, Joy ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ANIMAL EXPERIMENT; ARTICLE; CAT; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; CATS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; FEMALE; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; MALE; METABOLIC CLEARANCE RATE; TIME FACTORS;

ANIMALIA; FELIS CATUS;

EID: 0030848888     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Grant SM, Clissold SP. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycoses. Drugs 1989;3:310-344.
2. Cleary JD, Taylor JW, Chapman SW. New drug developments. Itraconazole in antifungal therapy. Ann Pharmacother 1992; 26:502-509.
3. Tucker RM, Williams PL, Arathoon EG, et al. Treatment of mycoses with itraconazole. Ann NY Acad Sci 1988;544:451-470.
4. Hart DT, Lauwers WJ, Willemens G, et al. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Mol Biochem Parasitol 1989;33:123-134.
5. Bosscher HV. Itraconazole: a selective inhibitor of the cytochrome P-450 dependent ergosterol biosynthesis. In: Recent trends in the discovery, development, and evaluation of antifungal agents. Barcelona, Spain: JR Prouse Science, 1987;201-222.
6. De Coster R, Beerens D, Haelterman C, et al. Effects of itraconazole on the pituitary-testicular-adrenal axis: an overview of preclinical and clinical studies. In: Recent trends in the discovery, development, and evaluation of antifungal agents. Barcelona, Spain: JR Prouse Science, 1987;251-262.
7. van Custum J, van Gerven F, Janssen PAJ. The in vitro and in vivo antifungal activity of itraconazole. In: Recent trends in the discovery, development, and evaluation of antifungal agents. Barcelona, Spain: JR Prouse Science, 1987;177-192.
8. van Cauteren H, Coussement W, Vandenberghe J, et al. The toxicological properties of itraconazole. In: Recent trends in the discovery, development, and evaluation of antifungal agents. Barcelona, Spain: JR Prouse Science, 1987;262-271.
9. Ward H. Itraconazole for the treatment of histoplasmosis in cats. J Vet Intern Med 1994;8:409-413.
10. Mundell AC. New therapeutic agents in veterinary dermatology. Vet Clin North Am Small Anim Pract 1990;20:1541-1556.
11. Medleau L, Jacobs GJ, Marks MA. Itraconazole for the treatment of cryptococcosis in cats. J Vet Intern Med 1995;9:39-42.
12. Medleau L, Green CE, Rakish PM. Evaluation of ketoconazole and itraconazole for treatment of disseminated cryptococcosis in cats. Am J Vet Res 1990;51:1454-1548.
13. Van Peer A, Woestenbourghs R, Heykants J, et al. The effects of food and dose on the oral systemic availability of itraconazole in health subjects. Eur J Clin Pharmacol 1989;36:423-426.
14. Hardin TC, Graybill JR, Techick R, et al. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother 1988;9:1310-1313.
15. Heykants J, Michiels M, Meuldermans W, et al. The pharmacokinetics of itraconazole in animals and man. An overview. In: Recent trends in the discovery, development, and evaluation of antifungal agents. Barcelona, Spain: JR Prouse Science, 1987;223-250.
16. Baggott J. Principles of drug disposition in domestic animals: the basis of veterinary clinical pharmacology. Philadelphia: WB Saunders Co, 1977;73-112.
17. Woestenborghs R, Lorreyne W, Heykants J. Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography. J Chromatogr Biomed Appl 1987;413:332-337.
18. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1982;445-450.
19. Yamoaka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
20. Borgers M. Changes in fungal ultrastructure after itraconazole treatment. In: Recent trends in the discovery, development, and evaluation of antifungal agents. Barcelona, Spain: JR Prouse Science, 1987;193-206.
21. McGinnis MR, Rinaldi MG. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing and assays of activity in biological fluids. In: Lorian V, ed. Antibiotics in laboratory medicine. Baltimore: The Williams & Wilkms Co, 1991;432-492.